By detecting the expression of kinases at the gene level in the PI3K/HDAC pathways with the CCLE database, we found that the expression levels of ErbB2 and ErbB3 in hematologic tumor cells were lower than those in solid tumors. Here, ERBB2 is linked to hematopoietic and lymphoid cell neoplasm.